This presentation from WHO was made at the launch of the 2020 Status Report of the National Implementation of the International Code of the Marketing of Breast-milk Substitutes.

These three briefs, published in 2021, explain the Bangladesh Breast-Milk Substitutes Act and what specific stakeholders - company owners, health administrators and the media -  need to know about it.

This policy brief summarizes the key provisions of the Bangladesh Breastmilk Substitutes, Infant Foods, Commercially Manufactured Complementary Foods, and the Accessories Thereof (Regulation of Marketing) Act (the Bangladesh BMS Act), which was adopted by Parliament in 2013 and sup

In this in-depth investigative report, the Bureau of Investigative Journalism documents how multinational baby formula companies, such as Nestlé and Danone, are using social media to market to consumers in South East Asia in ways that raise serious concerns they may violate the BMS Code. 

Adopted in 2006, Decree 21 aimed to support optimal infant and young child feeding (IYCF) by limiting how and where breast milk substitutes can be promoted.

Exclusive breastfeeding for the first six months of life is the single most effective intervention for preventing child deaths.